TherapeuticsMD (TXMD) Amortization of Deferred Charges (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly Amortization of Deferred Charges came in at $231000.0 in Q1 2026, up 50.0% YoY from $154000.0 in Q1 2025, and up 50.0% on a QoQ basis from $154000.0 in Q1 2025.
TherapeuticsMD (TXMD) Amortization of Deferred Charges (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 10 years of Amortization of Deferred Charges data on file, last reported at $231000.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 50.0% year-over-year to $231000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (down 44.74% YoY) and the FY2025 annual result came in at $809000.0, up 4.93% from the prior year.
- Amortization of Deferred Charges improved to $231000.0 in Q1 2026, from $154000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $9.0 million in Q1 2022 to a low of $154000.0 in Q1 2025.
- A 3-year average of $4.0 million and a median of $2.6 million in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges soared 611.32% — and 2026, when it jumped 50.0%.
- Tracing TXMD's Amortization of Deferred Charges over 3 years: stood at $2.6 million in 2022, then tumbled by 94.04% to $154000.0 in 2025, then jumped by 50.0% to $231000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $231000.0 (Q1 2026), $154000.0 (Q1 2025), and $2.6 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 234,000.00 |
| Jun 30, 2026 | 234,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Sep 30, 2022 | 2.58 Mn |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 7.92 Mn |
| Jun 30, 2022 | 7.92 Mn |
| Mar 31, 2022 | 9.05 Mn |
| Mar 31, 2022 | 9.05 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 1.48 Mn |
| Sep 30, 2021 | 1.48 Mn |
| Jun 30, 2021 | 1.41 Mn |
| Jun 30, 2021 | 1.41 Mn |
| Mar 31, 2021 | 1.27 Mn |
| Mar 31, 2021 | 1.27 Mn |